Literature DB >> 29507636

Novel amide-functionalized chloramphenicol base bifunctional organocatalysts for enantioselective alcoholysis of meso-cyclic anhydrides.

Lingjun Xu1, Shuwen Han1, Linjie Yan1, Haifeng Wang1, Haihui Peng1, Fener Chen1.   

Abstract

A family of novel chloramphenicol base-amide organocatalysts possessing a NH functionality at C-1 position as monodentate hydrogen bond donor were developed and evaluated for enantioselective organocatalytic alcoholysis of meso-cyclic anhydrides. These structural diversified organocatalysts were found to induce high enantioselectivity in alcoholysis of anhydrides and was successfully applied to the asymmetric synthesis of (S)-GABOB.

Entities:  

Keywords:  alcoholysis desymmetrization; bifunctional organocatalysis; chloramphenicol base

Year:  2018        PMID: 29507636      PMCID: PMC5815282          DOI: 10.3762/bjoc.14.19

Source DB:  PubMed          Journal:  Beilstein J Org Chem        ISSN: 1860-5397            Impact factor:   2.883


Introduction

Over the past decade, remarkable advances in the utilization of natural products as chiral structural motifs for the design of bifunctional organocatalysts have been achieved. A high stereocontrol in alcoholytic catalytic asymmetric desymmetrizations of meso-cyclic anhydrides is of special interest [1-7]. Major families originating from natural products include cinchona alkaloids [8-17] and proteinogenic α-amino acids such as proline [18-20] and valine [21] etc. [22-29], while fully synthetic catalysts are rare, only involving Brønsted acid/base catalysts [30], cyclohexanediamine catalysts [31-32], and diphenylethylenediamine catalysts [33-34]. Significant progress in our laboratory has been made in the development of chiral bifunctional urea 1 [35], thiourea 2 and 3 [36-37], sulfonamide 4 [38-40] and squaramide 5 [38-40] catalysts derived from chloramphenicol base (Figure 1), which showed excellent reactivity and enantioselectivity for this asymmetric transformation. A typical example of the great utility of chloramphenicol base scaffold in industrial production of enantiopure compounds is the synthesis of a precursor of biotin (vitamin H) by the chloramphenicol base-promoted asymmetric methanolysis of meso-cyclic anhydrides [41-43].
Figure 1

Chloramphenicol-base-derived bifunctional organocatalysts.

Chloramphenicol-base-derived bifunctional organocatalysts. Despite extensive studies on chloramphenicol-base-derived bifunctional derivatives catalyzed asymmetric alcoholysis of anhydride, the exploration of new effective and easily accessible fully synthetic organocatalysts through further modification of this privilege motif are always needed. Our present design is inspired by cinchona-derived sulfonamides, first developed by Song and co-workers [44-46]. Because of its easy availability and unique stereochemical aspect, we were therefore intrigued by the possibility of modifying the chloramphenicol base structural backbone by virtue of substituting the hydroxy group at C-1 position by a simple amide moiety as monodentate hydrogen bond donor to activate the electrophile (anhydride), whilst retaining the tertiary amine functionality to activate the nucleophile (alcohol, Figure 2). As part of our ongoing research program on chloramphenicol base organocatalysis, herein, we report a new class of chloramphenicol-derived bifunctional amide organocatalysts and their application for enantioselective alcoholysis of meso-cyclic anhydrides.
Figure 2

Design of new chloramphenicol base amide organocatalysts.

Design of new chloramphenicol base amide organocatalysts. In the precedented urea- or thiourea-based organocatalytic methanolysis of anhydrides, one big problem is the homo-aggregation of the catalysts via hydrogen bonding, which decreased the reactivity and enantioselectivity and required diluted concentrations with low temperatures [47]. With the new chloramphenicol base amide organocatalysts we envisioned that the presence of a bulky oxygen group could avoid the intermolecular aggregation of the catalyst, while keeping the desired bifunctional Brønsted acid/base reactivity for enantioselective desymmetrization of anhydrides [48-49].

Results and Discussion

A series of new chloramphenicol based-amide bifunctional catalysts 7a–q (Scheme 1) were synthesized from the appropriate optically pure (1R,2R)-diamine 6, prepared via several steps from chloramphenicol base [50]. In general, the synthesis is straightforward and well-compatible to electronically-diversified amides. Particularly, electron-deficient amides performed better. With 3,5-(CF3)2-disubstituted amide, the corresponding pruduct 7i was achieved with 90% yield. Different protecting groups for the nitrogen at the C-2 position and oxygen at C-3 are also investigated to yield the desired chiral catalysts using a simple procedure.
Scheme 1

Synthesis of bifunctional amide catalysts 7a–q.

Synthesis of bifunctional amide catalysts 7a–q. With various bifunctional catalysts in hand, assessment of their catalytic behavior in enantioselective alcoholysis of meso-cyclic anhydride 8a was carried out in various conditions with 10 equivalents of methanol. Resultingly, this novel Brønsted acid/base catalysts 7a–q proved to be sufficiently active and gave the monoester product with high yield and superior enantioselectivity, suggesting the unique reactivity of this amide-based chloramphenicol scaffold. Electronic effects were first investigated. Generally, electron deficient catalysts gave better reactivity and enantioselectivity than electron-rich variants (Table 1, entries 1–9). Among them, 7i performed best with 95% yield and 92% ee in 17 h (Table 1, entry 9). The surprising reactivity with this electron-poor 7i suggested that the pKa is crucial for this catalysis. Further modifications of the chloramphenicol skeleton with various protecting groups on the nitrogen at C-2 position and oxygen at C-3 did not improve the reaction but with lowered enantioselectivity (Table 1, entries 10–16). Notably, with methyl-protected catalyst 7q, this reaction proceeded with longer reaction time but with decreased enantioselectivity, suggesting the effects of a bulky ether group (Table 1, entry 17). Solvent effects were then evaluated and aprotic solvent performed better than protic solvents (Table 1, entries 18 and 19), which is in accordance with literature precedence [45]. Furthermore, changing concentration or low down the temperature of the reaction didn’t alter the yield or enantioselectivity, suggesting the concentration/temperature independence of this catalytic system (Table 1, entries 20–23). These results implicated that there is no significant aggregation of catalysts in this system.
Table 1

Conditions screening for asymmetric methanolysis of meso-cyclic anhydrides.


EntryCat.SolventConc. (M)T (°C)Time (h)Yielda (%)eeb,c (%)

17aMTBE0.0520349184
27bMTBE0.0520369480
37cMTBE0.0520409577
47dMTBE0.0520469480
57eMTBE0.0520489983
67fMTBE0.05205810078
77gMTBE0.0520969972
87hMTBE0.05204810076
97iMTBE0.0520179592
107jMTBE0.0520208580
117kMTBE0.0520589971
127lMTBE0.052021610058
137mMTBE0.0520289584
147nMTBE0.0520249176
157oMTBE0.05201929782
167pMTBE0.05202409868
177qMTBE0.0520589354
187iToluene0.0520149679
197iMeOH0.0520189110
207iMTBE0.012520869994
217iMTBE0.120129587
227iMTBE0.0501209995
237iMTBE0.05−203849296

aIsolated yield. bDetermined by HPLC after conversion to amide derivatives with (S)-1-phenylethylamine. cThe absolute configuration was determined by comparing with literature report.

Conditions screening for asymmetric methanolysis of meso-cyclic anhydrides. aIsolated yield. bDetermined by HPLC after conversion to amide derivatives with (S)-1-phenylethylamine. cThe absolute configuration was determined by comparing with literature report. This bifunctional Brønsted acid/base catalyst 7i proved to be highly active toward asymmetric methanolysis of various meso-cyclic anhydrides. As shown in Table 2, various cyclic anhydrides were conveniently converted into the corresponding monoester products in high yields and enantioselectivities. Notably, bicyclic anhydrides (Table 2, entries 1 and 2) and tricyclic anhydrides (Table 2, entries 3 and 4) were more reactive than mono-cyclic anhydrides (Table 2, entries 5–12). In the case of mono-substituted cyclic substrates, including alkyl- (Table 2, entries 5–7), ether- (entry 8), aryl-substitution (entries 9–11), moderate enantioselectivities were detected. Moreover, the chiral mono-substituted products are versatile key building blocks for the synthesis of a variety of the industrially important pharmaceuticals, such as γ-aminobutyric acid (GABA) and γ-amino-β-hydroxybutyric acid (GABOB) analogues (baclofen HCl and pregabalin) [51-54], HMG-CoA reductase inhibitors (“statins”) [55-57], etc.
Table 2

Asymmetric methanolysis of meso-cyclic anhydrides.a,b.


EntryAnhydrideProductTime (h)Yieldc (%)eed (%)

18a9a179895
28b9b609790
38c9c669473
48d9d669584
5 e8e9e848781
6 e8f9f849180
7 e8g9g849094
8e8h9h849781
98i9i608977
108j9j728778
118k9k849279
128l9l969180

aUnless otherwise noted, reactions were carried out with anhydride (0.5 mmol), MeOH (5.0 mmol), and 7i (10 mol %) in MTBE (10 mL) at rt. bAbsolute configuration was determined by comparing with literature report. cIsolated yield. dDetermined by HPLC after after derivatization. eIn MTBE (40 mL) at 0 °C.

Asymmetric methanolysis of meso-cyclic anhydrides.a,b. aUnless otherwise noted, reactions were carried out with anhydride (0.5 mmol), MeOH (5.0 mmol), and 7i (10 mol %) in MTBE (10 mL) at rt. bAbsolute configuration was determined by comparing with literature report. cIsolated yield. dDetermined by HPLC after after derivatization. eIn MTBE (40 mL) at 0 °C. The generality and scope of this methodology was further demonstrated in the alcoholysis of 8a with different alcohols (Table 3). Excellent yields with high enantioselectivities were obtained in all cases. The sterically more bulky 2-propanol worked well in this reaction. Allylic alcohol, benzyl alcohol and cinnamyl alcohol were also well compatible in this bifunctional organocatalysis conditions to furnish the desired products.
Table 3

Asymmetric alcoholysis of anhydride 8a with various alcohols.a


EntryROHMonoesterTime (h)Yieldb (%)eec,d (%)

1methanol9a179895
2ethanol9m969793
32-propanol9n989389
4allylic alcohol9o849085
5benzyl alcohol9p669886
6cinamyl alcohol9q669990

aUnless otherwise noted, above reactions were carried out with anhydride (0.5 mmol), MeOH (5.0 mmol), and catalyst 7i (10 mol %) in MTBE (40 mL) at rt. bIsolated yield. cDetermined by HPLC after derivatization. dAbsolute configuration was determined by comparing with the literature report.

Asymmetric alcoholysis of anhydride 8a with various alcohols.a aUnless otherwise noted, above reactions were carried out with anhydride (0.5 mmol), MeOH (5.0 mmol), and catalyst 7i (10 mol %) in MTBE (40 mL) at rt. bIsolated yield. cDetermined by HPLC after derivatization. dAbsolute configuration was determined by comparing with the literature report. Application of this methodology to the synthesis of (S)-GABOB (13), a metabolic derivative of the neurotransmitter γ-aminobutanoic acid, was performed to illustrate the synthetic utility [58-59] (Scheme 2). From commercially available diethyl 3-hydroxyglutarate (10), anhydride 8h was prepared in three steps in 54% overall yield. The crucial chloramphenicol base amide 7i catalyzed enantioselective alcoholysis gave monoester 9h in multigram scale. The resulting monoester with the desired stereocenter at C-3 was converted to triprotected derivative of GABOB 11 via Curtius rearrangement in 75% yield over two steps. After Pd/C-catalyzed hydrogenative deprotection of hydroxy group in methanol under acidic conditions, the corresponding alcohol 12 was transferred to the product 13 via acid-promoted deprotection. A single recrystallization from ethanol allowed 13 to be isolated with 96% ee and 73% yield.
Scheme 2

Asymmetric synthesis of (S)-GABOB (13).

Asymmetric synthesis of (S)-GABOB (13).

Conclusion

In conclusion, we developed a unique bifunctional chiral organocatalyst via introducing a simple amide functionality at C-1 of the easily available chloramphenicol scaffold, which shows good catalytic reactivity and enantioselectivity in the alcoholytic desymmetrization of meso-cyclic anhydrides. This method proved to be generally applicable on various anhydrides or alcohols to generate the desired monoesters in good yield and enantioselectivity. The application of this method to the synthesis of (S)-GABOB demonstrated the great synthetic potential for pharmaceutically useful chemicals. Further modification of this chloramphenicol scaffold as well as total synthesis of other natural chemicals are right now ongoing in our lab.

Experimental

General procedure for the synthesis of 9

Similarly as described in [37], with stirring under an atmosphere of nitrogen, alcohol (5 mmol, 10 equiv) was added dropwise to a solution of an anhydride 8 (0.5 mmol, 1 equiv) and 7i (0.05 mmol, 10 mol %) in MTBE (20 mL) at room temperature. The reaction was monitored by using thin-layer chromatography. Once the reaction was completed, the solvent was evaporated under reduced pressure and the residue was dissolved in CH2Cl2 (10 mL). The solution was successively washed with saturated Na2CO3 (2 × 5 mL), acidified with excess 2 N HCl, followed by extraction with EtOAc (3 × 10 mL). The combined organic phase were dried over Na2SO4 and concentrated to afford the corresponding monoester, without further purification by flash chromatography. Detailed experimental procedures, 1H NMR files.
  35 in total

1.  Asymmetric alcoholysis of cyclic anhydrides.

Authors:  Yonggang Chen; Paul McDaid; Li Deng
Journal:  Chem Rev       Date:  2003-08       Impact factor: 60.622

2.  Highly enantioselective conjugate addition of nitromethane to chalcones using bifunctional cinchona organocatalysts.

Authors:  Benedek Vakulya; Szilárd Varga; Antal Csámpai; Tibor Soós
Journal:  Org Lett       Date:  2005-05-12       Impact factor: 6.005

3.  Mimicry of polyketide synthases--enantioselective 1,4-addition reactions of malonic acid half-thioesters to nitroolefins.

Authors:  Jana Lubkoll; Helma Wennemers
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

4.  Self-association-free dimeric cinchona alkaloid organocatalysts: unprecedented catalytic activity, enantioselectivity and catalyst recyclability in dynamic kinetic resolution of racemic azlactones.

Authors:  Ji Woong Lee; Tae Hi Ryu; Joong Suk Oh; Han Yong Bae; Hyeong Bin Jang; Choong Eui Song
Journal:  Chem Commun (Camb)       Date:  2009-10-16       Impact factor: 6.222

5.  Catalytic Asymmetric Inverse-Electron-Demand 1,3-Dipolar Cycloaddition of C,N-Cyclic Azomethine Imines with Azlactones: Access to Chiral Tricyclic Tetrahydroisoquinolines.

Authors:  Xihong Liu; Yijie Wang; Dongxu Yang; Jinlong Zhang; Dongsheng Liu; Wu Su
Journal:  Angew Chem Int Ed Engl       Date:  2016-05-11       Impact factor: 15.336

6.  Bifunctional organocatalysts for the enantioselective synthesis of axially chiral isoquinoline N-oxides.

Authors:  Ryota Miyaji; Keisuke Asano; Seijiro Matsubara
Journal:  J Am Chem Soc       Date:  2015-05-22       Impact factor: 15.419

7.  Organocatalytic enantioselective desymmetrisation.

Authors:  A Borissov; T Q Davies; S R Ellis; T A Fleming; M S W Richardson; D J Dixon
Journal:  Chem Soc Rev       Date:  2016-06-27       Impact factor: 54.564

8.  Kinetic resolution of oxazinones: an organocatalytic approach to enantiomerically pure beta-amino acids.

Authors:  Albrecht Berkessel; Felix Cleemann; Santanu Mukherjee
Journal:  Angew Chem Int Ed Engl       Date:  2005-12-01       Impact factor: 15.336

9.  Bifunctional Ammonium Salt Catalyzed Asymmetric α-Hydroxylation of β-Ketoesters by Simultaneous Resolution of Oxaziridines.

Authors:  Johanna Novacek; Joseph A Izzo; Mathew J Vetticatt; Mario Waser
Journal:  Chemistry       Date:  2016-10-20       Impact factor: 5.236

10.  Asymmetric Synthesis of Vitamin D3 Analogues: Organocatalytic Desymmetrization Approach toward the A-Ring Precursor of Calcifediol.

Authors:  Haifeng Wang; Linjie Yan; Yan Wu; Yipei Lu; Fener Chen
Journal:  Org Lett       Date:  2015-10-28       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.